Morgan Stanley has issued a report maintaining an Overweight Rating on Stryker Corporation SYK.
According to the report, "In total, SYK reported an in-line quarter and maintained guidance, and our thesis remains intact. Gross margins, MedSurg performance and to a lesser extent taxes warrant further discussion."
SYK has a $68 Price Target and closed at $59.16 a share yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in